3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Pain
4
Breakthrough Cancer Pain
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Sarcoma
1
Quality of Life
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Ovarian Neoplasms
1
Neuralgia
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
Surveys and Questionnaires
2
nabiximols
1
Tapentadol
1
Plastic Surgery Procedures
1
Oxycodone
1
Morphine
1
Methadone
1
Hydromorphone
1
Fentanyl
1
Buprenorphine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neuralgia
×
Fentanyl
×
Clear all
NCT01946555
2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
150 enrolled